期刊文献+

他克莫司致肾移植受者突发性耳聋1例

Sudden hearing loss in a tacrolimus-treated post-renal transplantation recipient
原文传递
导出
摘要 1例患者肾移植术后规律服用他克莫司(4mg po bid) 4 d后,患者突发单侧右耳耳聋,当天血药浓度为15. 1ng·mL^(-1),医生调整他克莫司剂量,降低患者体内血药浓度到10. 6ng·mL^(-1)后,患者听力恢复正常。考虑突发性耳聋不良反应很可能是由他克莫司导致的。 Apatient presented sudden hearing loss with the unilateral right ear after taking tacrolimus (4 mg po bid) for four days after renal transplantation,and the blood concentration of tacrolimus increased to 15.1 ng·mL^-1 at that time.Doctors adjusted the dose of tacrolimus thus reduced the blood concentration to 10.6 ng·mL^-1 The patient′s hearing recovered then.It is likely that the adverse reaction of sudden hearing loss was caused by tacrolimus.
作者 李莉莉 吴新安 杨辉 LI Li-li;WU Xin-an;YANG Hui(Department of Pharmacy,Hefei BOE Hospital Co.,LTD.,Hefei 230012,China;Department of Pharmacy,Beijing Chaoyang Hospital,Capital Medical University,Beijing 100020,China)
出处 《临床药物治疗杂志》 2018年第7期86-88,共3页 Clinical Medication Journal
关键词 他克莫司 肾移植术后 突发性耳聋 tacrolimus post-renal transplantation sudden hearing loss
  • 相关文献

参考文献4

二级参考文献41

  • 1金晶,郑树森,王伟林.MDR-1和CYP3A基因多态性在肝肾移植中的应用[J].国外医学(移植与血液净化分册),2005,3(2):42-45. 被引量:2
  • 2Yong Yong SHI,Lin HE.SHEsis,a powerful software platform for analyses of linkage disequilibrium,haplotype construction,and genetic association at polymorphism loci[J].Cell Research,2005,15(2):97-98. 被引量:382
  • 3Kino T, Hatanaka H, Hashimoto M, et al. FK-506, a novel immunosuppressant isolated from a Streptomyees. I. fermentation, isolation, and physieo-ehemieal and biologi- cal characteristics [ J ] . J Antibiot, 1987, 40 (9) : 1249-1255.
  • 4Lerut J, Mathys J, Verbaandert C, et al. Tacrolimus monotherapy in liver transplantation: one-year results of a prospective, randomized, double-blind, placebo-controlled study[J]. Ann Surg, 2008, 248 (6): 956- 967.
  • 5Vincenti F, Jensik SC, Filo RS, et al. A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years [ J ]. Transplantation, 2002, 73 ( 5 ) : 775- 782.
  • 6Meier M, Nitschke M, Weidtmann B, et al. Slowing the progression of chronic allograft nephropathy by conversion from cyclosporine to tacrolimus: a randomized controlled trial[J]. Transplantation, 2006, 81 (7): 1035-1040.
  • 7Singh RP, Stratta RJ. Advances in immunosuppression for pancreas transplantation [ J ]. Curr Opin Organ Transplant, 2008, 13 (1): 79-84.
  • 8Pirsch JD, Miller J, Deierhoi MH, et al. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transp/antation. FK506 Kidney Transplant Study Group [J]. Transplantation, 1997, 63 (7) : 977-983.
  • 9Jensik SC. Tacrolimus (FK506) in kidney transplantation: three-year survival results of the US multicenter, randomized, comparative trial. FKS06 Kidney Transplant Study Group[J]. Transplant Proc, 1998, 30 (4) : 1216-1218.
  • 10Vineenti F. Tacrolimus (FKS06) in kidney transplantation: five-year survival results of the U.S. multicenter, randomized, comparative trial [ J ] . Transplant Proc, 2001, 33 (1-2): 1019-1020.

共引文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部